ARTCLINE GmbH Alternatives & Competitors
12 companies similar to ARTCLINE GmbH — Innovative therapeutic procedures for Intensive Care Medicine for the treatment...
Companies similar to ARTCLINE GmbH
Kite Pharma
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
ImmusanT
Pioneering advancements for celiac disease through innovative diagnostics and therapeutic...
Rival Readout
Competing with ARTCLINE GmbH? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
VaxCell Biotherapeutics Co., Ltd.
The Better life with Anti-cancer immunotherapy
Immunaeon
Connecting Today's Science to Tomorrow's Cures
Carbon Biosciences
Expanding Therapeutic Potential with Novel Parvovirus Gene Therapy
Abintus Bio, Inc.
Empowering patients from within
Immuneel Therapeutics Pvt. Ltd.
Accelerating access to Cell & Gene Therapies
Taiga Biotechnologies
Taiga Biotechnologies is a clinical stage biotechnology company focused on harnessing the...
About ARTCLINE GmbH
ARTCLINE GmbH, headquartered in Germany and founded in 2007, is pioneering the field of intensive care medicine through innovative therapy methods grounded in immune cell research. Their primary focus is the ARTICE technology, designed to effectively combat bacterial sepsis, a critical concern in global healthcare. Fue...
Development of innovative therapeutic procedures, Solutions for intensive care medicine
Hospitals, Healthcare Providers, Clinicians, Medical Researchers
Intensive Care Medicine, Innovative Therapy Methods, Immune Cell-Based Therapies, Sepsis Treatment, Bacterial Sepsis, Immunology, Sepsis Diagnostics, Cell Biological Research, Clinical Research, Industrial Application, Medical Inventions, University-Industry Collaboration, Medical Devices Development, Drug Development
B2B, B2D
Licensing, Product Sales, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around ARTCLINE GmbH: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at ARTCLINE GmbH on 14 May 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 11 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.